FindTrial
Sign In

Measurement of Choroidal Thickness in the eyes of Systemic Lupus Erythematosus Patients

Choroidal Thickness in Systemic Lupus Erythematosus Patients- A Spectral Domain Optical Coherence Tomography Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048801
Enrollment
85
Registered
2023-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Sponsors

Dr Smriti Choudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Patients with diagnosis of Systemic Lupus Erythematosus visiting the Department of Ophthalmology and rheumatology Department of Medicine at Kasturba Hospital, Manipal.

Exclusion criteria

Exclusion criteria: Patients with other retinal diseases and systemic diseases which can affect the choroidal vasculature and choroidal thickness, Pregnant SLE patients.

Design outcomes

Primary

MeasureTime frame
To study the choroidal thickness in SLE patients using SD-OCT and correlate it with SLE disease activity.Timepoint: 6 monthly (20/06/2023, 20/12/2023, 20/06/2024, 20/12/2024)—

Secondary

MeasureTime frame
To correlate choroidal thickness in SLE patients with SLE Disease Activity Index, Hypertension, Lupus Nephritis, Treatment with Hydroxychloroquine, Treatment with Corticosteroid.Timepoint: 6 monthly (20/06/2023, 20/12/2023, 20/06/2024, 20/12/2024)—

Countries

India

Contacts

Public ContactDr Smriti Choudhary

Kasturba Hospital, MAHE

smriti.choudhary@learner.manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026